Mesial temporal lobe epilepsy: A West Indian Neurosurgical Experience
- PMID: 31756688
- PMCID: PMC6872800
- DOI: 10.1016/j.ijscr.2019.10.063
Mesial temporal lobe epilepsy: A West Indian Neurosurgical Experience
Abstract
Introduction: We sought to highlight a case of refractory mesial temporal lobe epilepsy managed via an anterior temporal lobectomy. To our knowledge, this is the first of its kind to be performed and published in the English-speaking Caribbean.
Presentation of case: A 44-year-old female, known seizure disorder for 25 years was referred to the outpatient clinic. Several trials of varying anti-epileptic drugs failed to provide remittance of her frequent partial seizures over the last two decades. Magnetic resonance imaging displayed asymmetry of the hippocampus, with a prominent right temporal horn of lateral ventricle, in keeping with right anteromesial temporal lobe sclerosis. She underwent a right anterior temporal lobectomy after exhaustive counselling; with the guidance of a multidisciplinary team. The post-operative period was uneventful and currently, the patient has been seizure-free since operation.
Discussion: Drug resistant epilepsy is defined as failure of adequate trials of two tolerated, appropriately chosen and used anti-epileptic drug schedules to attain sustained seizure freedom. Medical management of mesial temporal lobe epilepsy has a relatively poor long-term outcome, with 30 % of patients falling into the category of pharmaco-resistant.
Conclusion: Surgical management of these cases have been proven to be a safe and effective alternative but is currently greatly underutilized. In our literature review, we present the first published case of epilepsy surgery in the English-speaking Caribbean for temporal lobe epilepsy.
Keywords: Anterior temporal lobectomy; Caribbean; Case report; Medical refractory epilepsy; Mesial temporal lobe epilepsy.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Figures



Similar articles
-
Gamma Knife radiosurgery for recurrent or residual seizures after anterior temporal lobectomy in mesial temporal lobe epilepsy patients with hippocampal sclerosis: long-term follow-up results of more than 4 years.J Neurosurg. 2015 Dec;123(6):1375-82. doi: 10.3171/2014.12.JNS141280. Epub 2015 Jul 10. J Neurosurg. 2015. PMID: 26162046
-
Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy.Epilepsia. 2016 Feb;57(2):325-34. doi: 10.1111/epi.13284. Epub 2015 Dec 24. Epilepsia. 2016. PMID: 26697969
-
Low-dose stereotactic radiosurgery is inadequate for medically intractable mesial temporal lobe epilepsy: a case report.Seizure. 2001 Sep;10(6):442-6. doi: 10.1053/seiz.2001.0519. Seizure. 2001. PMID: 11701000
-
Current management and surgical outcomes of medically intractable epilepsy.Clin Neurol Neurosurg. 2013 Dec;115(12):2411-8. doi: 10.1016/j.clineuro.2013.09.035. Epub 2013 Oct 11. Clin Neurol Neurosurg. 2013. PMID: 24169149 Review.
-
Surgical treatment for mesial temporal lobe epilepsy associated with hippocampal sclerosis.Rev Neurol (Paris). 2015 Mar;171(3):315-25. doi: 10.1016/j.neurol.2015.01.561. Epub 2015 Mar 3. Rev Neurol (Paris). 2015. PMID: 25746582 Review.
Cited by
-
Symptomatic central nervous system tuberculosis and human herpesvirus-6 coinfection with associated hydrocephalus managed with endoscopic third ventriculostomy: A case report and review of human herpesvirus-6 neuropathology.Surg Neurol Int. 2024 Aug 16;15:287. doi: 10.25259/SNI_355_2024. eCollection 2024. Surg Neurol Int. 2024. PMID: 39246759 Free PMC article.
References
-
- Pan American Health Organization . Pan American Health Organization; Washington, D.C: 2018. The Management of Epilepsy in the Public Health Sector.
-
- Pan American Health Organization . Reg. Work. (Trinidad Tobago, 28 Febr.–1 March 2018), Washington, D.C. Pan American Health Organization; 2018. Improving the management of epilepsy and its comorbidities in the Caribbean.http://iris.paho.org/xmlui/handle/123456789/49152
-
- Cramer J.A., Mintzer S., Wheless J., Mattson R.H. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev. Neurother. 2010;10:885–891. - PubMed
-
- Asadi-Pooya A.A., Stewart G.R., Abrams D.J., Sharan A. Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017 - PubMed
-
- Agha R.A., Borrelli M.R., Farwana R., Koshy K., Fowler A.J., Orgill D.P., Zhu H., Alsawadi A., Noureldin A., Rao A., Enam A., Thoma A., Bashashati M., Vasudevan B., Beamish A., Challacombe B., De Wilde R.L., Machado-Aranda D., Laskin D., Muzumdar D., D’cruz A., Manning T., Healy D., Pagano D., Goel P., Ranganathan P., Pai P.S., Raja S., Ather M.H., Kadioäžlu H., Nixon I., Mukherjee I., Gómez Rivas J., Raveendran K., Derbyshire L., Valmasoni M., Chalkoo M., Raison N., Muensterer O., Bradley P., Roberto C., Afifi R., Rosin D., Klappenbach R., Wynn R., Giordano S., Basu S., Surani S., Suman P., Thorat M., Kasi V. The SCARE 2018 statement: updating consensus Surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2018;60:132–136. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials